2020(09)LCX0181(AAR)
AAR-GUJARAT
M/s Shukla Ashar Impex Pvt. Ltd
decided on 17/09/2020
GUJARAT AUTHORITY FOR ADVANCE
RULING
GOODS AND SERVICES TAX
A/5, RAJYA KAR BHAVAN, ASHRAM ROAD,
AHMEDABAD – 380 009.
ADVANCE RULING NO. GUJ/GAAR/R/80/2020
(IN APPLICATION NO. Advance Ruling/SGST&CGST/2019/AR/58)
Date: 17.09.2020
Name and address of the applicant | : | M/s Shukla Ashar Impex Pvt. Ltd., 205, Nr. Vivekananda Statue, Yagnik Road, Rajkot-360021 (Gujarat) |
GSTIN of the applicant | : | 24AAJCS4670G1Z9 |
Date of application | : | 01.11.2019 |
Clause(s) of Section 97(2) of CGST / GGST Act, 2017, under which the question(s) raised. | : |
(a) Classification of goods and/or services or both. |
Date of Personal Hearing | : | 17.08.2020 (through video conferencing) |
Present for the applicant | : | Rushi Ashokbhai Upadhyay |
B R I E F FA C T S
The applicant, M/s. Shukla
Ashar Impex Private Limited, 205, Nr. Vivekananda Statue, Yagnik Road, Rajkot
(herein after referred to as the “applicant” for the sake of the brevity) is
engaged in the manufacturing of Mosquito Repellent, named it as “AAYUDH- MOSX”,
which is their brand name. They are manufacturing the above item for the purpose
of use on the skin toward off mosquitoes.
2. For the purpose of manufacturing the product, they have used all the natural
plant extracts. They have applied for the certification from Ayurvedic
Department and the same has been granted. (Certificate from Ayurvedic Department
attached herewith).
Section 3(a) of Drugs & Cosmetics Act, 1940 states that ‘Ayurvedic, Siddha or
Unani drugs includes all medicaments intended for internal or external use
(Diagnosis) mitigation or prevention of diseases or disorder in human beings,
animals and manufactured exclusively in accordance with the formulae described
in authoritative books of ayurvedic/ siddha and Unani Tibb system of medicine,
specified in the First Schedule.
3. On going through the HSN specified for the Mosquito Repellent, they have
found 30049011 for Ayurvedic Medicaments. However, for Mosquito Repellent, they
have also found HSN 38089191.
4. Now, they are not in a position to classify the same under which of the
heading same may be classified and, therefore, they have filed this Advance
Ruling application to avoid the future litigations and long appeal procedures.
Grounds of Application:
5. They are going to start the manufacturing of the above product and as earlier
stated that they are classifying the same under the tariff heading 3004 as they
are considering it as a ‘Ayurvedic product’ and classifiable under the tariff
sub heading 3004.
6. As they all know that main aim of GST is One Nation, One Tax and One Market
and which will create the healthy competition in the market and every seller is
selling the same product at same price so that the consumer will get benefit of
the same.
7. Manufacturing Industry is very well established in India, more so in case of
Mosquito Repellent and specifically in Gujarat, and considering the aim of GST
any difficulty in operating the business should be nullified as early as
possible and therefore filling this application
8. They have narrated some of the facts of the Product AAYUDH-MOSX (i.e.
Aayurvedic Mosquito Repellent) as under:
(i) Product Description:
AAYUDH-MOSX is a certified Ayurvedic mosquito repellent (certification attached
as annexure-A). Unlike other mosquito repellents in the market, AAYUDH-MOSX is
made from all-natural plant extracts and does not contain DEET (N,
N-Diethyl-meta-toluamide). Users can simply spray AAYUDH-MOSX on exposed skin
and surrounding areas toward off mosquitoes. AAYUDH-MOSX is safe on sensitive
skin and does not sweet easily like other cream-based repellents. In addition,
AAYUDH- MOSX is safe for new-borns and infants and safe upon accidental
ingestion.
(ii) Ingredients used to manufacture-AAYUDH-MOSX:
I. Coconut extracts: (Cocos Nucifera): Coconut oil is also a main ingredient in
Ayurvedic oils used for Mycobacteris TB, Topical Applications.
II. Sugar Cane Extracts: Saccharum officinarum.
III. Corn Extracts: Ref: Protection of Environment, EPA on Alkanolamines and
Esters.
IV. Lemongrass Oil: Cymbopogon Citrarus.
V. Citronella Oil.
VI. EDTA: Could be used as an Active Excipient.
VII. Water.
Product AAYUDH-MOSX is manufactured from above Ingredients and it can be seen
that all the ingredients are natural extracts which is also certified by the
Food and Drug Control Department, Gandhinagar. Form 25-D i.e. Licence to
Manufacture Ayurvedic drugs and List of Ingredients certified by the said
Department are attached herewith as Annexure-B. The said licence has been issued
under the Drugs and Cosmetics Act, 1940.
(iii) Process in Brief:
The Corn, Sugarcane and Coconut Extracts are blended in a sequence at varied
temperatures and pressures to ensure an even mix. Palm Fatty Oils help blending.
EDTA could be added as a Chelating agent. Essential oils, namely lemon grass oil
and citronella oil, may then be added as per need of application for added
affectivity to the mix. Water is added to ensure good solubility and evenness
along with Sugarcane and the Coconut processed extracts. The process is finally
ended with a process for binding these molecules into colloids and converting
them into Nano particles of 2-50 nano meters for far greater affectivity.
This would form a totally natural, non-toxic, biodegradable and a
non-carcinogenic, food grade and Ayurved certified (certification attached)
mosquito repellent, AAYUDH-MOSX.
9. Relevant Portion of Chapter 3004 reproduced hereunder:
30.04 MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06):
CONSISTING OF TWO OR MORE CONSTITUENTS WHICH HAVE BEEN MIXED TOGETHER FOR
THERSPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (INCLUDING THOSE IN
THE FORM OTTHOSE IN THE FORM OF TRANSDERMSL ADMINISTRATION SYSTEMS) OR IN FORMS
OR PACKAGING FOR RETAIL SALE.
3004.90— Other
—-of Ayurvedic, Unani, Homeopathic, Siddha or Bio-chemic systems Medicaments-put
up for Retail Sale;
30049011— of Ayurvedic System.
The heading also excludes:
(a)—————
(b)—————
(c)———————
(d)——————–
(e) Insecticides, disinfectants, etc., of heading 38.08, not put for internal or
external use as medicines.
The heading includes:
Mixed medicinal preparations such as those listed in an official pharmacopoeia,
proprietary medicines, etc., including those in the form of gargles, eye drops,
ointments, liniments, injections counter- irritant and other preparation not
falling in heading 30.02, 30.05 or 30.06”
10. Product AAYUDH-MOSX is a medicinal preparation and ingredients is also
mentioned in the book “BHAVA PRAKASHA”. Book is popularly known as “BHP”. BHP
book reference is also given by the Food and Drug Control Department,
Gandhinagar while granting the Ayurvedic License for their said product. (Refer
to Annexure-B-Page No.22). BHP Book is also mentioned at Schedule 1 against
Serial Number 11 of the Drugs and Cosmetics Act, 1940 (Schedule is attached as
Annexure C) and therefore it can be said that it is authoritative book and all
the ingredients mentioned in the book are Aayurvedic and, therefore, their
product contains the ingredients mentioned in the said book and therefore it can
be said that product AAYUDH-MOSX is AAYURVEDIC medicaments and properly
classifiable under heading 3004.
11. Further, they have submitted Study of Citronella leaf (One of the
ingredients used to manufacture AAYUDH-MOSX) based herbal mosquito repellents
using natural binders authored by renowned personalities in the Technology and
Research organisations. It has been said in the said article that Citronella
grass has been serving from years as a mosquito repellent in the field of
ancient and modern medicine. Commercially available mosquito repellents are
chemical based and disastrous to human health. It has been concluded in the
said article that addition of Citronella oil showed lesser residual percentage
with average burning time of 20 minutes and can be considered as good mosquito
repellent.
12. As regards Lemongrass (One of the ingredients used to manufacture
AAYUDH-MOSX), they have submitted research paper on ‘Investigation of the
Repellence Activity of BIO-OUT, A natural Mosquito Repellent’, as Annexure E. In
the said research paper, Lemongrass essential oil has been investigated for its
repellent activity against mosquitoes. It has been concluded from the tests
performed that the results obtained show that lemon grass essential oil provide
great protection against mosquitoes like that of DEET based ones. To make a good
natural repellent that will last up to 6 hours per application it is hoped that
mixing lemon grass oil with other herbal oils like neem, eucalyptus, etc.. It is
recommended in the said research paper that people should consider the use of
lemon grass oil as mosquito repellent apart from using chemical based
repellents.
13. Applicant has also got tested the said product with Saurashtra University,
Central of Excellence, Government of Gujarat and they have studied Herbal Nano
Particles manufactured by applicant and it has been concluded that Herbal Nano
Particles manufactured by Applicant based computational docking and simulation
studies against mosquito protein shows it can work as Repellent and Larvicide
both. (Research study also submitted by them, as Annexure-F).
14. Relevant Portion of Chapter 38.08:
38.08 INSECTICIDES, RODENTICIDES, FUNGICIDES, HERBICIDES, ANTI – SPROUTING
PRODUCTS AND PLANT-GROWTH REGULATORS, DISINFECTANTS AND SIMILAR PRODUCTS, PUT
UP IN FORMS OR PACKINGS FOR RETAIL SALE OR AS PREPARATIONS OR ARTICLES (FOR
EXAMPLE, SULPHUR-TREATED BANDS, WICKS AND CANDLES, AND FLY-PAPERS) (+).
15. They have also referred Chapter heading 3808 91 91 Repellents for insects
such as files, Mosquito which is being manufactured from various chemicals,
whereas products manufactured by applicant is not being manufactured from any
chemicals. The product does not kill the flies or mosquito, it just prevents.
Hence, it cannot be considered as insecticide or pesticide and foes not cover
under insecticides Act, 1940. The products manufactured by them are as per the
ingredients prescribed in “BHAVA PRAKASHAN” authoritative books under Ayurvedic
systems.
16. Further, they have referred Chapter Note 1 to Chapter 38 under which some
products have been excluded from Chapter 38. At (d) of Chapter Note 1 to Chapter
38, it has been mentioned that this chapter does not cover medicaments falling
under Chapter heading No.3003 or 3004. Further in case of M/s Monita Containers
V CCE (2007) 213 ELT 262, CESTAT held that chapter note prevails over heading of
chapter. The products manufactured by applicant falls under 3004 90 11-
Ayurvedic, Unani, Homeopathic, Siddha or Bio-Chemic Systems Medicaments-put up
for retail sales (of Ayurvedic Systems). Hence, cannot be covered under Chapter
heading 38089191 by virtue of (d) of Chapter Note 1 of Chapter 38.
17. Further, they have referred the HSN 38.08 and it has been described as
under:
“This heading covers a range of products (other than those having the
character of medicaments, deluding veterinary medicaments–heading 30.03 or
30.04) intended to destroy pathogenic germs, insects (mosquitoes, moths,
Colorado beetles, cockroaches etc.), mosses and moulds, weeds, rodents, wild
birds, etc. Products intended to repelpests or used for disinfecting seeds are
also classifiable here.
These insecticides, disinfectants, herbicides, fungicides etc. are applied by
spraying, dusting, sprinkling, coating, impregnating etc. or may necessitate
combustion.
They achieve their results by nerve poisoning, by stomach-poisoning, by
asphyxiation or by odour, etc.
The heading further covers anti-sprouting products and plant-growth regulators
intended to inhibit or promote physiological processes in plants. Their modes of
application ruction of the plant to enhanced growth-vigour and improve
crop-yield.
The products of heading 38.08 can be divided into the following groups:
(I) Insecticides
(II) Fungicide
(III) Herbicide
(IV) Disinfectants
This heading excludes:
(a)——-
(ii) —
(iii) ——-
(vi) ——-
(b)—————————
(i) —————
(ii) ————–
(iii) ———–
(c) Disinfectants, insecticides, etc., having the essential character of
medicaments, including veterinary medicaments (heading 30.03 or 30.04).
(d) ———-“
18. By going through both the Chapters Viz. 3004 and 3808 it is to state that
product if having the medicinal properties and having the therapeutic or
prophylactic uses, the same may be classifiable under heading 3004.
Furthermore, by going through chapter 3004, it has been given that heading
covers medicinal preparations for use in internal or external treatment or
prevention of human or animal ailments.
Product AAYUDH-MOSX is used for the external treatment for prevention of the
body from being infected by the bite of the mosquitos.
19. Further, they have taken the report of the laboratory named Accuprec
Research Labs Pvt. Ltd., approved by the Food & amp; Drug
Administration, Gujarat State, Gandhinagar having Licence No. GTL/37/31 and they
have certified that the test material ‘AAYUDH-MOSX’ supplied by the applicant
was tested for the Mosquito repellent activity and it can be concluded that
AAYUDH-MOSX when applied at dose of 3.25 and 6.5 gm (on Forearm) possess 100%
repellency. (Report Attached herewith as Annexure G).
19.1 Test carried out by the above laboratory named as “Comparative mosquito
repellent efficiency of AAAYUDH-MOSX and Standard Mosquito repellent against
Local mosquito” and for the purpose of the same standard repellent was taken
from the market i.e. “ODOMOS”. Experiment was carried out by applying 3.25 gm of
AAYUDH-MOSX and ODOMOS on forearm.
19.2 In the case of Commissioner of Sales Tax V S.S. Balsara Hygien Products
Ltd. reported in1986 UPTC 367, Odomos has been held as a medicine. The Court
held as under:
“There cannot be dispute about the fact that Odomos is used only as
mosquitoes repellent. The purpose is to save the human skin from mosquitoes
which results in several infectious disease; and mostly Malarial Fever etc. It
is true that it is not used as a medicine to cure some disease or to heal up
some wound but it is certainly a preventive medicine which prevents the body
from being infected by the bite of the mosquitoes. One redeeming feature which
has also been mentioned by the Tribunal in its order is that manufacturing of
this commodity is controlled by the authorities under the Drugs and Cosmetics
Act, 1940, which also lends support to the contention of the respondent-assessee
that it is used like a medicine”.
“It has been contended by the department that Odomos is available even in
general stores merchandise shops and is not sold at the Chemist shop
exclusively. In my opinion, the mere fact that Odomos is available even in
general merchandise shops will not detract the substance from being used as a
preventive medicine. It is well settled that common parlance meaning has to be
applied while interpreting entries under the fiscal statute and Courts have said
time and again that it is not safe to be always guided by the dictionary or
technical meanings. It is, therefore, not necessary to deal with various
authorities cited by the learned Counsel for the assessee on the point. Since in
common parlance Odomos is used as a medicine and is known as a medicine, in my
opinion.”
19.3. By going through the above, it can be said that AAYUDH-MOSX is also a
Medicament used to prevent the body from being infected by the bite of the
mosquitoes and, therefore, same is also a medicine merit classification under
the heading 3004 as like ODOMOS.
20. Further, they have also taken the certification from the Ayurveda that it is
an Ayurvedic product. Furthermore, AAYUDH-MOSX is prepared from Ayurvedic
ingredients and having Therapeutic or Prophylactic uses and, therefore, the same
is classifiable under heading 3004.
21. Further, by going through the heading and chapter notes 1 (d) of chapter
Heading 38.08, it clearly mentioned that heading covers range of products other
than those having character of medicaments, deluding veterinary medicaments of
heading 30.03 or 30.04.
22. Product AAYUDH-MOSX is having the Character of medicaments and, therefore,
they are of the considered opinion that the same is classifiable under heading
30.04.
23. In view of the above, they want to rely on some of the Case Laws in which
the product is prepared from Ayurvedic ingredients and having therapeutic or
Prophylactic Quality, same is classifiable under Chapter 30, which are as under:
(i) Global Tele Mall Vs Union of India reported at 2018 (18) G.S.T.L. 227 (M.P.),
it has been held that product prepared from Ayurvedic Ingredients and having
therapeutic quality classifiable as Ayurvedic Medicine under Chapter 30
(Attached as Annexure H).
(ii) Commissioner of Central Excise Pondicherry Vs Vale Exports (P) Ltd.
reported at 2018 (359) E.L.T. 211 (Tri. Chennai) in the said order at Para No.7
reference has been given of the Apex Court decision in case of Ciens
Laboratories reported at 2013 (295) E.L.T. 3 (S.C.). The Prescription of the
Apex Court is that a product that is used in curing or treating ailments or
disease and contains curative ingredients even in small quantities is to be
classified as medicaments and merit Classification under Chapter 30. (Attached
as Annexure-I).
(iii) Hon’ble Supreme Court while deciding the issue in case of State of UP v
Malik Zarid Khalid- AIR 1988 SC 123 held that Ayurvedic, Unani, Siddha,
Homeopathic or Bio chemic medicines manufactured exclusively in accordance with
formulae described in authoritative books specified in the First Schedule to
Drug and Cosmetics act, 1940 were classifiable under sub-heading no. 3003 CET
and that test for medicaments under chapter Note 2 to Chapter 30 were not
required to be satisfied.
24. Now, therefore, in view of the above submission, the applicant finds that
the appropriate heading for their product, AAYUDH-MOSX is heading 3004 and not
under the heading 3808. However, for the clarification in the matter and removed
the doubt, they are here before Advance Ruling authority for clarification in
the matter for avoiding future legal battle and simultaneous Consequences.
25. All the documents including Report of Center of Excellence, Lab Report,
Study of Citronella Leaf, Research Paper on Lemon Grass oil, Ayurveda Licence,
Schedule 1 to Drug and Cosmetics Act, 1940, Relied upon Judgements, Product
Literature and Sample Product attached herewith requesting the authority to give
the classification as regards their Product AAYUDH-MOSX.
26. In view of above backdrops, the applicant has put forward his question on
which advance ruling is required, as under:
“Product Mosquito Repellent, “Aayudh-Mosx” whether classifiable under
Heading 30049011 or 38089191?”
27. At the time of personal hearing held through Video Conferencing on
17.08.2020, the Authorised Representative of the applicant, Rushi Ashokbhai
Upadhyay, reiterated the facts as stated in the Application.
27.1 Further, the applicant has furnished an additional submission dated
19.08.2020 wherein they stated that during the course of PH, they have relied
upon the decision of State of UP v. Malik Zarid Khalid (AIR 1988 SC 132) which
has been referred in case of Shree Baidyanath Ayurved Vhavan Ltd. V.
Commissioner-2003 (157) E.L.T. A260 (S.C.) and it has been asked to submit the
same. In this regard, the applicant stated that Shree Baidyanath case has been
finally decided by the Supreme Court reported at 2009 (237) E.L.T. 225 (S.C.)
and same has been distinguished vide decision in the case of Commissioner of
Central Excise V. Wockardt Life Science Ltd., reported at 2012 (277) E.L.T. 299
(S.C.), while deciding the issue Supreme Court had held as under:
“HELD : Purpose of use was primarily prophylactic and to prevent infection or
disease – In that view, it was classifiable as medicament under Heading 3003 of
Central Excise Tariff, a specific entry and not under sub-heading 3402.90
thereof, a residuary entry – Note 2(i) of Chapter 30 ibid made it clear that
products, comprising two or more constituents which have been compounded
together either for therapeutic or prophylactic uses, would fall within meaning
of expression ‘Medicament’ – Revenue plea that since impugned product was
primarily used as detergents/cleansing preparation, they cannot be brought under
definition of medicaments, rejected. [paras 15, 29, 34]
Classification of goods – Determination of – Factors to be considered are
product composition, its literature, label, character and user – Process of
manufacture and end use, is not necessarily determinative – What is more
important is whether broad description of article fits in with expression used
in Tariff – Functional utility and predominant usage of commodity must be taken
into account, apart from understanding in common parlance – However, there
cannot be static parameter for correct classification. [paras 31, 32, 34]
Classification of goods – Determination of – There is no fixed test – ‘Common
parlance test’ or ‘commercial usage test’ are most common – Whether particular
article will fall within particular Tariff heading or not has to be decided on
basis of tangible material or evidence to determine how it is understood in
‘common parlance’ or in ‘commercial world’ or in its popular meaning or in
‘trade circle’; they are concerned with product and their understanding
constitutes definitive index of legislative intention, when statute was enacted.
[para 30]
Classification of goods – Under Chapter 30 of Central
Excise Tariff – One essential factor is whether article is understood as
pharmaceutical product in common parlance – However, quantity of medicament used
in particular product is not relevant – Normally, extent of use of medicinal
ingredients is very low because larger use may be harmful for human body. [para
30]”
DISCUSSION & FINDINGS:
28. We have considered the
submissions made by the applicant in their application for advance ruling as
well as at the time of personal hearing. We also considered the issue involved,
on which advance ruling is sought by the applicant, relevant facts & the
applicant’s interpretation of law.
28.1 At the outset, we would like to state that the provisions of both the CGST
Act and the GGST Act are the same except for certain provisions. Therefore,
unless a mention is specifically made to such dissimilar provisions, a reference
to the CGST Act would also mean a reference to the same provisions under the
GGST Act.
29. In the instant case, the applicant has sought advance ruling in respect of
following question:
30. On going through the submission given by the applicant, we find that the
applicant is engaged in the manufacturing of Mosquito Repellent, named as “AAYUDH-MOSX”.
31. The applicant has submitted that:
(i) the product, AAYUDH-MOSX is a certified Ayurvedic mosquito repellent. Unlike
other mosquito repellents available in the market, AAYUDH-MOSX is made from
all-natural plant extracts and does not contain DEET (N, N-Diethyl-meta-toluamide);
(ii) the said product is manufactured from natural extracts, viz. Coconut
extracts, Sugar Cane extracts, Corn extracts, Lemongrass oil, Citronella oil,
EDTA & Water, which is also certified by the Food and Drug Control Department,
Gandhinagar;
(iii) the manufacturing process of said product is as below:
The Corn, Sugarcane and Coconut Extracts are blended in a sequence at varied
temperatures and pressures to ensure an even mix. Palm Fatty Oils help blending.
EDTA could be added as a Chelating agent. Essential oils, namely lemon grass oil
and citronella oil, may then be added as per need of application for added
affectivity to the mix. Water is added to ensure good solubility and evenness
along with Sugarcane and the Coconut processed extracts. The process is finally
ended with a process for binding these molecules into colloids and converting
them into Nano particles of 2-50 nano meters for far greater affectivity.
(iv) This would form a totally natural, non-toxic, biodegradable and a
non-carcinogenic, food grade and Ayurved certified mosquito repellent, ‘AAYUDH-MOSX’.
(v) the said product is used on the skin toward off mosquitoes;
(vi) the said product is safe on sensitive skin and does not sweet easily like
other cream-based repellents. In addition, said product is also safe for new-borns
and infants and safe upon accidental ingestion;
(vii) AAYUDH-MOSX is also a Medicament used to prevent the body from being
infected by the bite of the mosquitoes and, therefore, same is also a medicine,
merits classification under the heading 3004 as like ODOMOS;
(viii) Further, they have also taken the certification from the Ayurveda that it
is an Ayurvedic product. Furthermore, AAYUDH-MOSX is prepared from Ayurvedic
ingredients and having Therapeutic or Prophylactic uses and, therefore, the same
is classifiable under heading 3004;
(ix) Further, by going through the heading and chapter notes 1 (d) of chapter
Heading 38.08, it clearly mentioned that heading covers range of products other
than those having character of medicaments, deluding veterinary medicaments of
heading 30.03 or 30.04;
(x) they placed reliance upon the following case laws in which the product is
prepared from Ayurvedic ingredients and having therapeutic or Prophylactic
Quality, same is classifiable under Chapter 30:
(a) Global Tele Mall Vs Union of India, reported at 2018 (18) G.S.T.L. 227 (M.P.);
(b) Commissioner of Central Excise Pondicherry Vs Vale Exports (P) Ltd.,
reported at 2018 (359) E.L.T. 211 (Tri. Chennai); and
(c) State of UP v Malik Zarid Khalid- reported at AIR 1988 SC 123.
(xi) In view of the above, the applicant stated that the appropriate heading for
their product, ‘AAYUDH-MOSX’ is 3004 and not 3808.
32. We find that the product in question i.e. ‘AAYUDH-MOSX’ is a Ayurvedic
mosquito repellent made from all-natural plant extracts and does not contain
DEET (N, N-Diethyl-meta-toluamide). Said product is used for prevention of the
body from being infected by the bite of the mosquitos. The applicant refers
Section 3(a) of the Drugs and Cosmetics Act, 1940 defines “Ayurvedic, Siddha or
Unani drug”.
33. The definitions of terms in statutes having different objectives, purposes
and schemes cannot be applied mechanically to fiscal statutes. The Hon’ble
Supreme Court in the case of Commissioner of Central Excise, Nagpur v. Shree
Baidyanath Ayurved Bhavan Limited, reported at (2009) 12 SCC 419 held thus:
“55. True it is that Section 3(a) of the Drugs and Cosmetics Act, 1940
defines “Ayurvedic, siddha or unani drug” but that definition is not necessary
to be imported in the new Tariff Act. The definition of one statute having
different object, purpose and scheme cannot be applied mechanically to another
statute. As stated above, the object of the Excise Act is to raise revenue for
which various products are differently classified in the new Tariff Act.”
34. By drawing inference from above, we find that the definition of the Drugs
and Cosmetics Act, 1940 having different object, purpose and scheme cannot be
applied mechanically to GST law. The object of the GST Act is to raise revenue
for which various products are differently classified in the Customs Tariff Act,
as also applicable to GST.
35. We find that the applicant pitched the product in their sale material and
advertisements as a mosquito repellent. Various mosquito repelling qualities are
identified as defining characteristics of the subject goods in the market.
36. We further note that the said product is not normally prescribed as a
medicine by medical practitioner as a drug. There is no restriction on sales.
The product is sold on demand at the counters in shops and establishments. Sales
are not restricted to chemists/druggists alone.
37. We further note that the product is a mosquito repellent by virtue of its
mosquito repelling characteristics and is so understood in common parlance. The
dealers identify and sell the product as a mosquito repellent. Customers
purchase the same and use it in the like manner.
38. In the wake of the said facts and findings, the common parlance test or the
market identity test for classification of the product is satisfied. We,
therefore, conclude that the product is a mosquito repellent.
39. The interpretation of various entries and headings relating to
classification of goods is guided both by the rules framed in that regard and
judicial authority in point.
40. In order to determine the classification and the tax liability under GST in
respect of supply of the said goods, we are required to refer to the
Notification No.01/2017-Central Tax (Rate) dated 28.06.2017 containing the
sub-headings as well as the rates of Central GST applicable to various goods,
which are covered under 6 Schedules, as below:
(i) 2. 5 per cent. in respect of goods specified in Schedule I,
(ii) 6 per cent. in respect of goods specified in Schedule II,
(iii) 9 per cent. in respect of goods specified in Schedule III,
(iv) 14 per cent. in respect of goods specified in Schedule IV,
(v) 5 per cent. in respect of goods specified in Schedule V, and
(vi) 125 per cent. in respect of goods specified in Schedule VI.
Further, Explanations (iii) and (iv) of the said Notification read as under:
(iii) “Tariff item”, “sub-heading” “heading” and “Chapter” shall mean
respectively a tariff item, sub-heading, heading and chapter as specified in the
First Schedule to the Customs Tariff Act, 1975 (51 of 1975).
(iv) The rules for the interpretation of the First Schedule to the Customs
Tariff Act, 1975 (51 of 1975), including the Section and Chapter Notes and the
General Explanatory Notes of the First Schedule shall, so far as may be, apply
to the interpretation of this notification.
41. The relevant entries under Heading 3808 of the Customs Tariff Act are as
under:
Tariff Item |
Description of goods |
3808 |
Insecticides, rodenticides, fungicides, herbicides, anti-sprouting products and plant-growth regulators, disinfectants and similar products |
3808 91 91 |
Repellents for insects such as flies and- mosquitoes |
42. The tariff heading, being favoured by the applicant is reproduced hereunder:
Tariff Item |
Description of goods |
3004 |
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
3004 90 99 |
Other |
43. The General Rules for
Interpretation of Import Tariff which guided us in determination of the
classification of the goods, will also aid this discussion. The relevant rules
are set out hereunder for ease of reference:-
“3. When by application of rule 2(b) or for any other reason, goods are,
prima facie, classifiable under two or more headings, classification shall be
effected as follows:
(a) The heading which provides the most specific description shall be preferred
to headings providing a more general description. However, when two or more
headings each refer to part only of the materials or substances contained in
mixed or composite goods or to part only of the items in a set put up for retail
sale, those headings are to be regarded as equally specific in relation to those
goods, even if one of them gives a more complete or precise description of the
goods.
(b) Mixtures, composite goods consisting of different materials or made up of
different components, and goods put up in sets for retail sale, which cannot be
classified by reference to (a), shall be classified as if they consisted of the
material or component which gives them their essential character, in so far as
this criterion is applicable.
(c) When goods cannot be classified by reference to (a) or (b), they shall be
classified under the heading which occurs last in numerical order among those
which equally merit consideration.”
44. Under rule 3 of the general interpretation rules, resort cannot be had to a
general entry called “others” or any other heading when the product clearly
falls under a specific classification heading.
45. In this regard, we place reliance of case laws in the case of
Commissioner of Central Excise, Nagpur v. Shree Baidyanath Ayurved Bhavan
Limited, reported at (2009) 12 SCC 419, wherein the Hon’ble Supreme
Court while interpreting the Rule 3 (a) of the aforesaid Rules held as under:
“56. There is no doubt that a specific entry must prevail over a general
entry. This is reflected from Rule 3(a) of the general Rules of interpretation
that states that Heading which provides the most specific description shall be
preferred to Headings providing a more general description.”
46. A perusal of the classification heading no. 38089191 shows that the product
in question is a neat fit into the description of products laid down therein. No
laboured process of reasoning is required since the heading No. 38089191, is
clear as day light.
47. The invocation of the general entry called “others” by the applicant is
clearly misconceived, since the product in question is covered by a specific
description in the heading under which the product has been classified.
48. The preceding discussion establishes that all attributes of mosquito
repellents relevant for a judicial enquiry of this nature are found in the
product in question.
49. The reliance placed by the applicant on the judgment of the High Court
rendered in the case of Commissioner of Sales Tax Vs. M/s S.S. Balsara
Hygiene Products Limited, reported at 1986 UPTC 367 (All.), wherein Odomos
has been held as a medicine, is misplaced. The entry which was under
consideration before said Court in M/s Balsara Hygiene Product Limited (supra)
issued under Section 3 of the Uttar Pradesh Sales Tax, 1948 and reads as
“Medicines and pharmaceutical preparations including insecticides and
pesticides. The said entry included insecticides and pesticides within the
broader category of medicines and pharmaceutical preparations. This is
incomplete contradistinction to the entry under the tariff heading no. 3808
which is in issue in this application. The rival classifications of medicament
vs mosquito repellent were not examined by said Court in the case of M/s Balsara
Hygiene Products Limited (supra) while the same are directly in issue in the
instant application before us.
49.1 In this regard, it is pertinent to mention that recently, in the case of
M/s Dabur India Ltd., the Hon’ble High Court of Allahabad, vide its Order
dated 17.01.2020 upholds the order of Appellate Authority for Advance Ruling
of Uttar Pradesh, holding “Odomos” to be a ‘mosquito repellent’ classifiable
under HSN 38089191 of Chapter 38 of Customs Tariff Act, 1975 (CTA) and not as a
‘medicament’ under Heading No. 3004.
50. We find that undoubtedly, the description under Heading No. 3808 91 91,
i.e., “Repellents for insects such as flies, mosquito” is far more specific as
compared to the description under the other heading under consideration, i.e.,
Heading No. 3004 90 99 which is “Other” (meaning medicaments other than all
those explicitly specified in the other sub-headings of Heading No. 3004).
Evidently, the latter heading is a residual classification while the former is
specific and conforms to the description of the goods adopted by the applicant
themselves for the purposes of packing as well as advertisement and publicity.
51. The Hon’ble Supreme Court also, in their judgment in the case of HPL
CHEMICALS LTD. VERSUS CCE, CHANDIGARH [2006 (4) TMI 1 – SUPREME COURT]], have
held that specific heading is preferable over residuary heading for
classification. Therefore, in terms of the aforesaid rules for interpretation,
Heading No. 3808 91 91 will prevail over 3004 90 99.
52. The appellant declares prominently on the packing of the goods under
reference that it is “mosquito repellent”. The advertisement and publicity of
these goods is also done as a mosquito repellent. It would also not be out of
place to mention that the applicant, themselves, describes ‘AAYUDH-MOSX’
as a ‘mosquito repellent’ – the market identity in common parlance of the
subject goods is as a ‘mosquito repellent’ and their usefulness in preventing
mosquito borne diseases (again derived from their characteristic quality of
being a mosquito repellent) is of a subsidiary/ supplementary nature.
53. We further note that the product, ‘AAYUDH-MOSX’ is not known in the market
as an ‘Ayurvedic medicine’ and the same is also not ordinarily prescribed by a
Physician as a medicine for prevention of the body from being infected by the
bite of the mosquitos.
54. It is pertinent that mosquito repellents are classified at Heading No. 3808
91 91 of the Customs Tariff as a subcategory of insecticides. Thus, this again
indicates that Heading No. 3808 91 91 is most specific for the classification of
the subject product.
55.1 We have also perused the case laws cited by the applicant. In the case of
M/s Global Tele Mall Vs Union of India, reported at 2018 (18) G.S.T.L. 227 (M.P.),
the dispute before High Court of MP was related to categorization of the goods,
viz. “Kashyog Oil and Keshyog Herbal Powder Hair Wash/Shampoo” either as
Ayurvedic medicine or cosmetic/toilet preparation and whether or not the
processes undertaken by the vendor will amount to manufacture. Hence, ratio of
this case is not applicable to the case before us being facts are
distinguishable.
55.2 In the case of Commissioner of Central Excise Pondicherry Vs Vale Exports
(P) Ltd. reported at 2018 (359) E.L.T. 211 (Tri. Chennai), the dispute, before
the CESTAT, Chennai was related to classification of ‘Fair Plus Herbal Face
Cream’ and ‘Fair Plus Face Lotion’ during Central Excise Regime. Hence, the
ratio of subject case will also not be applicable to the facts of the case
before us.
55.3 Further, they have also relied upon the decision of State of UP v. Malik
Zarid Khalid (AIR 1988 SC 132) which has been referred in case of Shree
Baidyanath Ayurved Vhavan Ltd. V. Commissioner-2003 (157) E.L.T. A260 (S.C.). In
this regard, the applicant stated that Shree Baidyanath case has been finally
decided by the Supreme Court reported at 2009 (237) E.L.T. 225 (S.C.) and same
has been distinguished vide decision in the case of Commissioner of Central
Excise V. Wockardt Life Science Ltd., reported at 2012 (277) E.L.T. 299 (S.C.).
In the case of Wockardt Life Science Ltd. supra, we find that the Hon’ble
Supreme Court has dealt with the classification of the classification of two
products viz. ‘Povidone Iodine Cleansing Solution USP and Wokadine Surgical
Scrub for the purpose of levy of duty under the provisions of Central Excise
Tariff Act, 1985 and not of Mosquito Repellent, hence, same is not applicable to
the facts of the present case.
56. All the factors relevant for classification under the Customs Tariff lead to
the classification of the Applicant’s product “AAYUDH-MOSX” under Heading No.
3808 91 91, be it the rules for interpretation of the said Tariff, the common
parlance test, or its usage and way of working.
57. In view of the above, we, therefore, hold that the product in question i.e.
‘AAYUDH-MOSX’, is a mosquito repellent used on the skin toward off mosquitoes
and, hence, same is classifiable under Chapter Heading No. 3808 91 91 of
the Customs Tariff Act, 1985 and not as a ‘medicament’ under Heading No. 3004.
AAYUDH-MOSX’, being a mosquito repellent, attracts GST @18% (CGST-9%+ SGST-9%),
as per Sl. No. 87 of Schedule-III to the Notification No.01/2017-Central Tax
(Rate) dated 28.06.2017, which reads as under:
Schedule III- 9%
SI. No. |
Chapter/Heading/ Sub Heading/ Tariff Item |
description of the goods |
87. |
3808 |
Insecticides, rodenticides, fungicides, herbicides, anti-sprouting products and plant-growth regulators, disinfectants and similar products. |
58. In light of the above discussions, we rule as under –
RULING
Question: “Product Aayudh-Mosx
whether classifiable under Heading 30049011 or 38089191?”
Answer: The product i.e. ‘AAYUDH-MOSX’, is a mosquito repellent and hence, it is
classifiable under Chapter Heading No. 3808 91 91 of the Customs Tariff Act,
1985, attracting GST @18% (CGST-9%+ SGST-9%).
(SANJAY SAXENA)
MEMBER
(MOHIT AGRAWAL)
MEMBER
Place: Ahmedabad
Date: 17.09.2020
Equivalent .